IDERA PHARMACEUTICALS INC (IDRA)

US45168K4058 - Common Stock

0.425  -0.12 (-21.57%)

After market: 0.42 -0.01 (-1.18%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
0.000.000.001.45M660.00K
Operating Expenses
17.36M26.35M36.69M47.34M57.26M
Research and Development
8.06M16.38M24.77M34.85M41.84M
Selling, General, and Administrative Expenses
9.34M9.98M11.92M12.48M15.42M
Operating Income
-17.36M-26.35M-36.69M-45.89M-56.60M
Interest Income/Expense
253.00K6.96M130.00K520.00K1.08M
Other Income/Expense
0.00118.80M-76.11M-10.96MN/A
Non Recurring Items
N/A-1.32M0.00-180.00K-4.36M
Income Before Taxes
-22.74M98.09M-112.66M-56.52M-59.88M
Income Tax
N/AN/AN/AN/AN/A
Net Income
-17.85M96.94M-112.66M-84.56M-59.88M
EBITDA
-17.34M-26.33M-36.63M-45.77M-56.17M
 
Per Share Data
EPS Diluted Total Ops
-0.341.93-3.33-2.96-2.25
Non GAAP EPS
N/A2.34-3.85-2.94-2.27
 
Statistics
Profit Margin
N/AN/AN/A-5831.72%-9072.73%
Operating Profit Margin
N/AN/AN/A-3164.83%-8575.76%

All data in USD

Charts